Novo Holdings’ investment alongside Biocomposites’ existing shareholder, TA Associates, will help the company scale its ...

A medical device company has secured investment from the owner of the developer of Ozempic and a private equity firm, to ...

Novo Holdings and TA Associates have agreed to make an investment into Biocomposites.

Leading health benefits provider, Simplyhealth ( has launched a suite of services and products for businesses to make healthcare more simple, affordable and accessible to the whole of the workforce.

Novo Holdings and TA Associates ("TA"), announced today that the parties have entered into an agreement for Novo Holdings to make an investment in Biocomposites ("the Company"), an international ...

Additional investment and resources will accelerate Biocomposites' international expansion and innovation in products for use in infection management HELLERUP, Denmark, LONDON and KEELE ...